Standout Papers

Androgen Deprivation Therapy (ADT) Plus Docetaxel Versus ADT Alone in Metastatic Non castrate Prosta... 2015 2026 2018 2022 300
  1. Androgen Deprivation Therapy (ADT) Plus Docetaxel Versus ADT Alone in Metastatic Non castrate Prostate Cancer: Impact of Metastatic Burden and Long-term Survival Analysis of the Randomized Phase 3 GETUG-AFU15 Trial (2015)
    Gwénaëlle Gravis, Jean‐Marie Boher et al. European Urology

Immediate Impact

78 standout
Sub-graph 1 of 17

Citing Papers

Lightweight and drift-free magnetically actuated millirobots via asymmetric laser-induced graphene
2024 Standout
Renal cell carcinoma
2024 Standout
2 intermediate papers

Works of Loı̈c Mourey being referenced

Second-line targeted therapies after nivolumab-ipilimumab failure in metastatic renal cell carcinoma
2019
Vinflunine–gemcitabine versus vinflunine–carboplatin as first-line chemotherapy in cisplatin-unfit patients with advanced urothelial carcinoma: results of an international randomized phase II trial (JASINT1)
2015

Author Peers

Author Last Decade Papers Cites
Loı̈c Mourey 838 550 246 267 106 1.4k
Gavin Marx 714 638 202 205 97 1.7k
J.F. Lester 990 613 239 152 82 1.5k
Damien Pouessel 768 812 211 592 117 1.7k
Ludwig Plaßwilm 530 371 202 269 94 1.6k
Yoshio Ohno 620 722 91 506 99 1.5k
Constance Thibault 540 561 129 270 96 1.1k
Koji Mitsuzuka 739 210 114 324 117 1.4k
Deepak Kilari 446 537 53 187 103 1.1k
Ciara M. Kelly 464 494 47 175 62 1.0k
Kosuke Kashiwabara 437 449 75 252 91 1.4k

All Works

Loading papers...

Rankless by CCL
2026